Hypoxia-Mediated ATF4 Induction Promotes Survival in Detached Conditions in Metastatic Murine Mammary Cancer Cells

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Jul 18

PMID 35847893

Authors

Violet A Kiesel

Madeline P Sheeley

Emily M Hicks

Chaylen Andolino

Shawn S Donkin

Michael K Wendt

Stephen D Hursting

Dorothy Teegarden

Affiliations

Soon will be listed here.

Abstract

Regions of hypoxia are common in solid tumors and drive changes in gene expression that increase risk of cancer metastasis. Tumor cells must respond to the stress of hypoxia by activating genes to modify cell metabolism and antioxidant response to improve survival. The goal of the current study was to determine the effect of hypoxia on cell metabolism and markers of oxidative stress in metastatic (metM-Wnt) compared with nonmetastatic (M-Wnt) murine mammary cancer cell lines. We show that hypoxia induced a greater suppression of glutamine to glutamate conversion in metastatic cells (13% in metastatic cells compared to 7% in nonmetastatic cells). We also show that hypoxia increased expression of genes involved in antioxidant response in metastatic compared to nonmetastatic cells, including glutamate cysteine ligase catalytic and modifier subunits and malic enzyme 1. Interestingly, hypoxia increased the mRNA level of the transaminase glutamic pyruvic transaminase 2 (Gpt2, 7.7-fold) only in metM-Wnt cells. The change in Gpt2 expression was accompanied by transcriptional (4.2-fold) and translational (6.5-fold) induction of the integrated stress response effector protein activating transcription factor 4 (ATF4). Genetic depletion ATF4 demonstrated importance of this molecule for survival of hypoxic metastatic cells in detached conditions. These findings indicate that more aggressive, metastatic cancer cells utilize hypoxia for metabolic reprogramming and induction of antioxidant defense, including activation of ATF4, for survival in detached conditions.

Citing Articles

PERK-Olating Through Cancer: A Brew of Cellular Decisions.

Mazzolini L, Touriol C Biomolecules. 2025; 15(2).

PMID: 40001551 PMC: 11852789. DOI: 10.3390/biom15020248.

Gluconeogenesis and glycogenolysis required in metastatic breast cancer cells.

Hicks E, Layosa M, Andolino C, Truffer C, Song Y, Heden T Front Oncol. 2024; 14:1476459.

PMID: 39479019 PMC: 11521782. DOI: 10.3389/fonc.2024.1476459.

ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer.

Chen J, Huang X, Zhang S, Zhu X Sci Rep. 2024; 14(1):13042.

PMID: 38844625 PMC: 11156644. DOI: 10.1038/s41598-024-63895-y.

attenuates the intestinal permeability, oxidative stress and endoplasmic reticulum stress: transcriptome and microbiome analyses in weaned piglets.

Yuan J, Meng H, Liu Y, Wang L, Zhu Q, Wang Z Front Microbiol. 2024; 15:1362487.

PMID: 38808274 PMC: 11131103. DOI: 10.3389/fmicb.2024.1362487.

Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis.

Li Y, He Q, He C, Cai C, Chen Z, Duan J ESC Heart Fail. 2023; 10(4):2510-2523.

PMID: 37290760 PMC: 10375070. DOI: 10.1002/ehf2.14404.

References

Blais J, Filipenko V, Bi M, Harding H, Ron D, Koumenis C . Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol. 2004; 24(17):7469-82. PMC: 506979. DOI: 10.1128/MCB.24.17.7469-7482.2004. View

Aggarwal V, Tuli H, Varol A, Thakral F, Yerer M, Sak K . Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules. 2019; 9(11). PMC: 6920770. DOI: 10.3390/biom9110735. View

Hao Y, Samuels Y, Li Q, Krokowski D, Guan B, Wang C . Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer. Nat Commun. 2016; 7:11971. PMC: 4915131. DOI: 10.1038/ncomms11971. View

Sun R, Denko N . Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab. 2014; 19(2):285-92. PMC: 3920584. DOI: 10.1016/j.cmet.2013.11.022. View

Ohshima K, Morii E . Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis. Metabolites. 2021; 11(1). PMC: 7824065. DOI: 10.3390/metabo11010028. View

Samanta D, Semenza G . Maintenance of redox homeostasis by hypoxia-inducible factors. Redox Biol. 2017; 13:331-335. PMC: 5476461. DOI: 10.1016/j.redox.2017.05.022. View

Samanta D, Park Y, Andrabi S, Shelton L, Gilkes D, Semenza G . RETRACTED: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis. Cancer Res. 2016; 76(15):4430-42. DOI: 10.1158/0008-5472.CAN-16-0530. View

Dunlap S, Chiao L, Nogueira L, Usary J, Perou C, Varticovski L . Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models. Cancer Prev Res (Phila). 2012; 5(7):930-42. PMC: 3822442. DOI: 10.1158/1940-6207.CAPR-12-0034. View

Endo H, Owada S, Inagaki Y, Shida Y, Tatemichi M . Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment. Redox Biol. 2020; 36:101643. PMC: 7371916. DOI: 10.1016/j.redox.2020.101643. View

10.

Kalyanaraman B, Darley-Usmar V, Davies K, Dennery P, Forman H, Grisham M . Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med. 2011; 52(1):1-6. PMC: 3911769. DOI: 10.1016/j.freeradbiomed.2011.09.030. View

11.

Syu J, Chi J, Kung H . Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia. Oncotarget. 2016; 7(12):14659-72. PMC: 4924742. DOI: 10.18632/oncotarget.7406. View

12.

Dey S, Sayers C, Verginadis I, Lehman S, Cheng Y, Cerniglia G . ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J Clin Invest. 2015; 125(7):2592-608. PMC: 4563676. DOI: 10.1172/JCI78031. View

13.

Chandel N, Maltepe E, GOLDWASSER E, Mathieu C, Simon M, Schumacker P . Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998; 95(20):11715-20. PMC: 21706. DOI: 10.1073/pnas.95.20.11715. View

14.

Long C, Antoniewicz M . High-resolution C metabolic flux analysis. Nat Protoc. 2019; 14(10):2856-2877. DOI: 10.1038/s41596-019-0204-0. View

15.

Ye J, Kumanova M, Hart L, Sloane K, Zhang H, De Panis D . The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 2010; 29(12):2082-96. PMC: 2892366. DOI: 10.1038/emboj.2010.81. View

16.

Cairns R, Mak T . Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 2013; 3(7):730-41. DOI: 10.1158/2159-8290.CD-13-0083. View

17.

Wei L, Lin Q, Lu Y, Li G, Huang L, Fu Z . Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation. Cell Death Dis. 2021; 12(4):334. PMC: 8007632. DOI: 10.1038/s41419-021-03574-2. View

18.

Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, Diehl J, Nagi C, Debnath J . PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol. 2011; 31(17):3616-29. PMC: 3165554. DOI: 10.1128/MCB.05164-11. View

19.

Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J . Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol. 2009; 29(10):2570-81. PMC: 2682037. DOI: 10.1128/MCB.00166-09. View

20.

Salgado M, Meton I, Anemaet I, Baanante I . Activating transcription factor 4 mediates up-regulation of alanine aminotransferase 2 gene expression under metabolic stress. Biochim Biophys Acta. 2014; 1839(4):288-96. DOI: 10.1016/j.bbagrm.2014.01.005. View